-
Facts and Stats
The Five Phases of Clinical ResearchNew treatments in the U.S. are scrutinized in various ways before and after they are approved by the Food and Drug Administration.
by Bradley Jones
-
Cancer Care’s Virtual RevolutionThe pandemic has made telehealth a necessity for many cancer patients. When the crisis clears, these technological tools may improve cancer care in the long term.
by Stephen Ornes
-
Immunotherapy Indications WithdrawnIn recent months, drugmakers have announced they are withdrawing indications for four immune checkpoint inhibitors in consultation with the Food and Drug Administration. What does this mean for patients who are taking these drugs?
by Anna Goshua
-
A Drive for DiversityAfrican Americans are underrepresented in the Be The Match bone marrow donor registry. Patient advocates are working to change that.
by Jon Kelvey
-
February 26: The Week in Cancer NewsNonprofits provide support to young cancer patients in need of fertility preservation, and a childhood cancer survivor joins the first all-civilian mission to space.
by Bradley Jones
-
Patient Advocates Tune in for Precision Medicine PrimerScientists and physicians discussed advances in targeted therapies and immunotherapies, as well as the lessons COVID-19 research has taught to cancer researchers.
by Kevin McLaughlin
-
Immunotherapy Options for Breast CancerTwo immune checkpoint inhibitors are now approved for treatment of some people with advanced breast cancer, but trial results have raised some questions.
by Anna Goshua
-
January 8: The Week in Cancer NewsTwo extremely rare cases of cancer being passed from mother to child observed in Japan, and advice on COVID-19 vaccines for cancer patients.
by Bradley Jones
-
Colorectal Cancer Screenings at HomeStool-based tests could increase access to colorectal cancer screening.
by Jen Tota McGivney
-
From the Editor-in-Chief
Intercepting Cancer by Tackling PrecancerResearch on premalignancy is needed to fully tap the potential of cancer interception.
by William G. Nelson, MD, PhD
U.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
Missed Activities Due to Cancer-related Fatigue and DepressionWomen were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.
by Eric Fitzsimmons
Immunotherapy Improves Results in Head and Neck CancerCombining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona
Federal Support for Cancer Research Takes the Stage at AACR Annual MeetingScientists and former administrators gather for session focused on advocating for cancer research in uncertain times.
by Kevin McLaughlin
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
